萬辰生物(300972.SZ):擬推2022年限制性股票激勵計劃
格隆匯9月23日丨萬辰生物(300972.SZ)公佈2022年限制性股票激勵計劃(草案),該激勵計劃擬授予激勵對象的限制性股票數量為575.00萬股,約佔該激勵計劃草案公佈日公司股本總額15,350.00萬股的3.75%。
其中,首次授予限制性股票460.00萬股,約佔該激勵計劃草案公佈日公司股本總額的3.00%,佔該激勵計劃擬授予限制性股票總數的80.00%;預留授予限制性股票115.00萬股,約佔該激勵計劃草案公佈日公司股本總額的0.75%,佔該激勵計劃擬授予限制性股票總數的20.00%。
根據激勵對象的不同類別特點,該激勵計劃的激勵對象分為第一類激勵對象與第二類激勵對象。其中,首次授予第一類激勵對象的限制性股票授予價格為8.78元/股,首次授予第二類激勵對象的限制性股票授予價格為6.27元/股。預留部分限制性股票授予價格與首次授予第二類激勵對象的限制性股票授予價格相同。
該激勵計劃首次授予的激勵對象共計52人,包括公司公吿該激勵計劃時在公司(含子公司,下同)任職的董事、高級管理人員、核心業務人員和骨幹員工,不含萬辰生物獨立董事、監事。
該激勵計劃的有效期為自限制性股票授予之日起至激勵對象獲授的限制性股票全部歸屬或作廢失效之日止,最長不超過48個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.